Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-17-035231
Filing Date
2017-06-30
Accepted
2017-06-30 16:12:52
Documents
1
Period of Report
2016-09-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 v468765_form3.html 3  
1 FORM 3 v468765_form3.xml 3 2506
  Complete submission text file 0001144204-17-035231.txt   3840
Mailing Address 750 LEXINGTON AVE NEW YORK NY 10022
Business Address
WEISS MICHAEL S (Reporting) CIK: 0001038977 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-55668 | Film No.: 17942349

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Issuer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 0312
SIC: 2834 Pharmaceutical Preparations